RecruitingPhase 2NCT04500665
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
Sponsor
Brigham and Women's Hospital
Enrollment
20 participants
Start Date
Nov 1, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.
Eligibility
Min Age: 21 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This study tests whether colchicine — an inexpensive anti-inflammatory medication often used for gout — can protect the heart in people with chronic kidney disease. People with kidney disease often develop a type of heart damage, and this study investigates whether reducing inflammation can help.
**You may be eligible if...**
- You are 21 to 80 years old
- You have reduced kidney function (eGFR between 15 and 75)
- Your urine test shows elevated protein levels (albumin-to-creatinine ratio above 30)
- You are on maximum tolerated doses of standard kidney-protective medications (ACE inhibitor or ARB) if applicable
**You may NOT be eligible if...**
- You are already on dialysis or have had a kidney transplant
- You have active liver disease
- You have a history of colchicine intolerance
- You are pregnant or planning to become pregnant
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGColchicine
Colchicine
DRUGPlacebo
Placebo
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04500665
Related Trials
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
NCT063378383 locations
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
NCT041858443 locations
Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients
NCT062867481 location
Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease
NCT062882042 locations
SPYRAL GEMINI Pilot Study
NCT0690714716 locations